FDA plans ultra-fast review of three psychedelic drugs following Trump directive
President Donald Trump signed an executive order last weekend directing the FDA and other federal agencies to speed research and loosen restrictions on psychedelics, a class of hallucinogenic drugs that remain illegal under federal law.